Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Hermans

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
Diabetes & Metabolic Syndrome|September 25, 2021
Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated with SGLT2 inhibitors: A review of 72 cases over a 4.5-year periodN Menghoum, P Oriot, M P Hermans
Acta Clinica Belgica|January 5, 2002
Therapy, glycaemic control and complications in type 1 diabetic patients: results from a single centre cohort of 465 subjectsS Deckers, M P Hermans, M Buysschaert
Acta Clinica Belgica|September 6, 2002
Clinical, biophysical and biochemical variables from African-heritage subjects with type 2 diabetesM P Hermans, C Dumont, M Buysschaert
Acta Clinica Belgica|January 1, 1997
[Treatment and glycemic control of 1200 diabetic patients enrolled at the National Institute of Disease-Disability Insurance diabetes convention]M Buysschaert, M Maes, M P Hermans
Biochimica Et Biophysica Acta|November 28, 1986
Role of the decrease in ionized calcium in the inhibition of insulin release by chloride-free solutionsM P Hermans, M Gérard, J C Henquin
Diabetologia|August 1, 1987
The permissive effect of glucose, tolbutamide and high K+ on arginine stimulation of insulin release in isolated mouse isletsM P Hermans, W Schmeer, J C Henquin
Endocrinology|May 1, 1987
Modulation of the effect of acetylcholine on insulin release by the membrane potential of B cellsM P Hermans, W Schmeer, J C Henquin
Diabetic Medicine : a Journal of the British Diabetic Association|September 5, 2002
The C282Y/wt heterozygous HFE genotype is associated with lower blood pressure and HDL-cholesterol in Type 2 diabetesM P Hermans, S Van Lerberghe, M Buysschaert
Diabetic Medicine : a Journal of the British Diabetic Association|May 10, 2006
The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetesM P Hermans, J-L Gala, M Buysschaert
Diabetic Medicine : a Journal of the British Diabetic Association|June 25, 2005
Prospective screening for biopsy proven coeliac disease, autoimmunity and malabsorption markers in Belgian subjects with Type 1 diabetesM Buysschaert, J P Tomasi, M P Hermans
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Diabetes & Metabolic Syndrome|September 25, 2021
Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated with SGLT2 inhibitors: A review of 72 cases over a 4.5-year periodN Menghoum, P Oriot, M P Hermans
Acta Clinica Belgica|January 5, 2002
Therapy, glycaemic control and complications in type 1 diabetic patients: results from a single centre cohort of 465 subjectsS Deckers, M P Hermans, M Buysschaert
Acta Clinica Belgica|September 6, 2002
Clinical, biophysical and biochemical variables from African-heritage subjects with type 2 diabetesM P Hermans, C Dumont, M Buysschaert
Acta Clinica Belgica|January 1, 1997
[Treatment and glycemic control of 1200 diabetic patients enrolled at the National Institute of Disease-Disability Insurance diabetes convention]M Buysschaert, M Maes, M P Hermans
Biochimica Et Biophysica Acta|November 28, 1986
Role of the decrease in ionized calcium in the inhibition of insulin release by chloride-free solutionsM P Hermans, M Gérard, J C Henquin
Diabetologia|August 1, 1987
The permissive effect of glucose, tolbutamide and high K+ on arginine stimulation of insulin release in isolated mouse isletsM P Hermans, W Schmeer, J C Henquin
Endocrinology|May 1, 1987
Modulation of the effect of acetylcholine on insulin release by the membrane potential of B cellsM P Hermans, W Schmeer, J C Henquin
Diabetic Medicine : a Journal of the British Diabetic Association|September 5, 2002
The C282Y/wt heterozygous HFE genotype is associated with lower blood pressure and HDL-cholesterol in Type 2 diabetesM P Hermans, S Van Lerberghe, M Buysschaert
Diabetic Medicine : a Journal of the British Diabetic Association|May 10, 2006
The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetesM P Hermans, J-L Gala, M Buysschaert
Diabetic Medicine : a Journal of the British Diabetic Association|June 25, 2005
Prospective screening for biopsy proven coeliac disease, autoimmunity and malabsorption markers in Belgian subjects with Type 1 diabetesM Buysschaert, J P Tomasi, M P Hermans
Pageof 8